Period Ending | Dec 30, 2012 | Dec 30, 2011 |
---|
Total Revenue
|
18,380,000
|
17,444,000
| Cost of Revenue | 4,508,000 | 4,639,000 | |
Gross Profit
|
13,872,000
|
12,805,000
| |
|
Operating Expenses |
|
Research Development | 2,778,000 | 2,618,000 |
|
Selling General and Administrative | 4,989,000 | 5,894,000 |
|
Non Recurring | 288,000 | 673,000 |
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
5,817,000
|
3,620,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (8,000) | 28,000 |
|
Earnings Before Interest And Taxes | 5,725,000 | 3,668,000 |
|
Interest Expense |
-
|
-
|
|
Income Before Tax | 5,725,000 | 3,668,000 |
|
Income Tax Expense | 450,000 | 235,000 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 5,275,000 | 3,433,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
5,275,000
|
3,433,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
5,275,000
|
3,433,000
|
|